Latest filing published 26 Jan 2026 for Arcus Biosciences, Inc.. Read the official filing
No signal scores available.
All filings by Richard Markus on record concern Arcus Biosciences, Inc. The record holds 3 filings, for trades running from 10 February 2025 to 23 January 2026.
Every open-market trade on record is a sale: 1 sale worth €94k. Besides market trades, the filings include 2 share grants.
The latest filing, published on 26 January 2026, reports a share grant in Arcus Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations